27/05/2025 08:07
EQS-News: Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitin-based ADC Candidate HDP-102 for Non-Hodgkin Lymphoma
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Study br/ Heidelberg Pharma Announces First Patient Dosed in Phase I Study of Amanitinbased ADC Candidate HDP102 for NonHodgkin Lymphoma... Lire...
15/05/2025 14:31
EQS-News: Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: AGM/EGM br/ Heidelberg Pharma Reports on the Results of the Ordinary Annual General Meeting 2025 and New Supervisory Board... Lire...
14/05/2025 18:40
EQS-News: Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP-101 at EHA 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma to Present Promising New Clinical Data on its Lead ATAC Candidate HDP101 at EHA 2025 br/br/ 14.05.2025... Lire...
24/04/2025 07:16
EQS-News: Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Quarterly / Interim Statement br/ Heidelberg Pharma AG: Interim Statement on the First Three Months of Financial Year 2025... Lire...
26/03/2025 09:23
EQS-News: Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Conference br/ Heidelberg Pharma to Present Data from its ADC Technology Platforms at AACR Annual Meeting 2025 br/br/ 26.03.2025 / 09:23... Lire...
21/03/2025 07:07
EQS-News: Heidelberg Pharma announces financial figures and reports on successful business performance in 2024
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Annual Report br/ Heidelberg Pharma announces financial figures and reports on successful business performance in 2024 br/br/ 21.03.2025... Lire...
13/03/2025 07:30
EQS-News: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Contract br/ Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty br/br/ 13.03.2025 / 07:30 CET/CESTbr/ The issuer... Lire...
13/03/2025 00:31
EQS-Adhoc: Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd pEQSAdhoc: Heidelberg Pharma AG / Key words: Contractbr/ Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty br/br/ 13March2025 / 00:31 CET/CESTbr/ Disclosure of an inside information acc. to... Lire...
13/01/2025 08:17
EQS-News: Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP-101 Targeting Multiple Myeloma
html xmlns=http://www.w3.org/1999/xhtmlbody table border=trtd p EQSNews: Heidelberg Pharma AG / Key words: Study br/ Heidelberg Pharma Progresses into Cohort 7 in a Phase I/IIa Study with BCMA ATAC Candidate HDP101 Targeting Multiple Myeloma... Lire...